| # | Drug | Count |
|---|---|---|
| 0 | IBUPROFEN | 28 |
| 1 | IBUPFROFEN | 18 |
| 2 | IBUPROFEN 200 MG | 18 |
| 3 | IBUPROFEN 200MG | 18 |
| 4 | IBUPROFEN CAPSULE | 18 |
| 5 | IBUPROFEN CAPSULES 200 MG | 18 |
| 6 | IBUPROFEN ORAL | 18 |
| 7 | IBUPROFEN TABLET, FILM COATED | 18 |
| 8 | IBUPROFEN TABLET, FILM-COATED | 18 |
| 9 | IBUPROFEN TABLETS USP, 200MG | 18 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NIVOLUMAB AND RELATLIMAB-RMBW | 1 | 0.0019 |
| 1 | MECASERMIN | 1 | 0.0012 |
| 2 | ESOMEPRAZOLE SODIUM | 1 | 0.0004 |
| 3 | BECLOMETHASONE DIPROPIONATE | 2 | 0.0003 |
| 4 | KETOPROFEN | 4 | 0.0003 |
| 5 | POVIDONE-IODINE | 1 | 0.0002 |
| 6 | IBUPROFEN SODIUM | 10 | 0.0002 |
| 7 | CARMUSTINE | 1 | 0.0002 |
| 8 | REPAGLINIDE | 1 | 0.0001 |
| 9 | PANITUMUMAB | 2 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Lymphocyte Activation Gene-3 Blocker [EPC] | 1 | 0.0019 |
| 1 | Antiseptic [EPC] | 1 | 0.0002 |
| 2 | Sigma-1 Agonist [EPC] | 2 | 0.0002 |
| 3 | Glinide [EPC] | 1 | 0.0001 |
| 4 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 1 | 0.0001 |
| 5 | Epidermal Growth Factor Receptor Antagonist [EPC] | 2 | 0.0000 |
| 6 | Oxazolidinone Antibacterial [EPC] | 1 | 0.0000 |
| 7 | Nonsteroidal Anti-inflammatory Drug [EPC] | 35 | 0.0000 |
| 8 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 4 | 0.0000 |
| 9 | Complement Inhibitor [EPC] | 1 | 0.0000 |